Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer

S. Torresan, G. Zussino, F. Cortiula*, A. Follador, G. Fasola, R. Girometti, L. Cereser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Radiation recall pneumonitis (RRP) is a rare inflammatory reaction that occurs in previously irradiated fields, and it may be caused by various triggering agents. Immunotherapy has been reported to potentially be one of these triggers. However, precise mechanisms and specific treatments have not been explored yet due to a lack of data in this setting. Here, we report a case of a patient who received radiation therapy and immune checkpoint inhibitor therapy for non-small cell lung cancer. He developed first radiation recall pneumonitis and subsequently immune-checkpoint inhibitor-induced pneumonitis (IIP). After presenting the case, we discuss the currently available literature on RRP and the challenges of differential diagnosis between RRP, IIP, and other forms of pneumonitis. We believe that this case is of particular clinical value since it highlights the importance of including RRP in a differential diagnosis of lung consolidation during immunotherapy. Furthermore, it suggests that RRP might anticipate more extensive ICI-induced pneumonitis.
Original languageEnglish
Article number1266
Number of pages8
JournalJournal of Clinical Medicine
Volume12
Issue number4
DOIs
Publication statusPublished - 1 Feb 2023

Keywords

  • NSCLC
  • radiotherapy
  • immunotherapy
  • pneumonitis
  • radiation recall reactions
  • radiation recall pneumonitis
  • ICI-related pneumonitis
  • radiotherapy related pneumonitis
  • radiomics
  • CHECKPOINT INHIBITOR
  • RISK-FACTORS
  • CHEMORADIOTHERAPY

Fingerprint

Dive into the research topics of 'Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this